WaveMan · Form 4
Bender Jeremy insider trades
> Search tickers & screens ⌘K
LIVE

Bender Jeremy insider trades

Bender Jeremy has filed 47 Form 4s with the SEC that we hold, for DAWN (CHIEF EXECUTIVE OFFICER, Director), Mereo BioPharma Group plc (MREO) (Director), FUSN (Director) and Aura Biosciences, Inc. (AURA) (Director), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 34 sales worth $5.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($320.9K). The largest single trade was a sale of 70,051 shares of DAWN worth $1.3M, dated 2024-05-01. The first filing on our record is dated 2022-01-20 and the latest 2026-07-29.

DAWN

CHIEF EXECUTIVE OFFICER, Director · 40 filings · 34 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-07-01S, sale reported on Form 41,746$34.9K2022-07-06
2022-07-05S, sale reported on Form 4857$17.1K2022-07-06
2022-07-08S, sale reported on Form 41,795$35.9K2022-07-12
2022-07-18S, sale reported on Form 42,600$52.0K2022-07-20
2022-08-04S, sale reported on Form 412,500$250.0K2022-08-05
2022-08-16S, sale reported on Form 44,003$97.3K2022-08-17
2022-09-01S, sale reported on Form 410,641$246.3K2022-09-06
2022-09-01S, sale reported on Form 41,859$44.2K2022-09-06
2022-09-01S, sale reported on Form 41,859$44.2K2022-09-06
2022-09-01S, sale reported on Form 410,641$246.3K2022-09-06
2022-10-03S, sale reported on Form 412,500$250.6K2022-10-05
2022-11-01S, sale reported on Form 412,500$250.4K2022-11-03
2022-11-16S, sale reported on Form 41,513$32.5K2022-11-17
2022-11-21S, sale reported on Form 412,100$251.0K2022-11-22
2022-11-21S, sale reported on Form 4400$8.6K2022-11-22
2022-12-21S, sale reported on Form 412,500$254.0K2022-12-22
2023-01-23S, sale reported on Form 412,500$275.0K2023-01-24
2023-02-16S, sale reported on Form 43,022$59.1K2023-02-17
2023-03-07S, sale reported on Form 412,500$250.1K2023-03-08
2023-05-16S, sale reported on Form 43,104$40.7K2023-05-17
2023-08-17S, sale reported on Form 42,996$41.5K2023-08-17
2023-11-16S, sale reported on Form 43,107$36.3K2023-11-17
2024-02-16S, sale reported on Form 47,615$116.1K2024-02-20
2024-05-01S, sale reported on Form 470,051$1.3M2024-05-03
2024-05-02S, sale reported on Form 46$1082024-05-03
2024-05-03S, sale reported on Form 49,154$163.4K2024-05-03
2024-05-16S, sale reported on Form 47,873$126.6K2024-05-17
2024-08-16S, sale reported on Form 410,681$149.5K2024-08-19
2024-11-18S, sale reported on Form 410,554$139.4K2024-11-19
2025-02-18S, sale reported on Form 412,048$144.1K2025-02-21
2025-05-16S, sale reported on Form 413,964$87.4K2025-05-19
2025-08-18S, sale reported on Form 416,058$108.7K2025-08-19
2025-11-17S, sale reported on Form 415,894$141.6K2025-11-18
2026-02-17S, sale reported on Form 415,459$179.3K2026-02-18

Mereo BioPharma Group plc (MREO)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

FUSN

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Aura Biosciences, Inc. (AURA)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Bicara Therapeutics Inc. (BCAX)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1863107) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms